Picture of Grace Therapeutics logo

GRCE — Grace Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: Acasti Announces Completion Of Patient Enrollment In Pivotal Phase 3 Strive-On Safety Trial Of Gtx-104

Sept 25 (Reuters) - Acasti Pharma Inc  ACST.O :
    * ACASTI ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN
PIVOTAL
PHASE 3 STRIVE-ON SAFETY TRIAL OF GTX-104

Source text for Eikon:  ID:nGNX889yxJ 
Further company coverage:  ACST.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Grace Therapeutics

See all news